Ventana Biotech Inc
Ventana Global Inc. provides various portfolio of loans. The company offers custom financial, borrower and lender network, business advising and mentoring, and cash flow services. It also provides consulting services to third party businesses and individuals. The company was formerly known as Ventana Biotech, Inc. and changed its name to Ventana Global Inc. in January 2015. Ventana Global Inc. is… Read more
Market Cap & Net Worth: Ventana Biotech Inc (VNTA)
Ventana Biotech Inc (PINK:VNTA) has a market capitalization of $591.62K ($591.62K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50043 globally and #15280 in its home market, demonstrating a -90.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ventana Biotech Inc's stock price $0.01 by its total outstanding shares 53783544 (53.78 Million).
Ventana Biotech Inc Market Cap History: 2015 to 2025
Ventana Biotech Inc's market capitalization history from 2015 to 2025. Data shows growth from $43.03K to $591.62K (30.29% CAGR).
Ventana Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ventana Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.30x
Ventana Biotech Inc's market cap is 14.30 times its annual revenue
1.78x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
29.74x
Ventana Biotech Inc's market cap is 29.74 times its annual earnings
0.83x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $21.51K | $31.84K | $17.28K | 0.68x | 1.24x |
| 2025 | $591.62K | $41.36K | $19.89K | 14.30x | 29.74x |
Competitor Companies of VNTA by Market Capitalization
Companies near Ventana Biotech Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Ventana Biotech Inc by market ranking:
- Visa Inc. Class A (NYSE:V): Ranked #20 globally with a market cap of $539.53 Billion USD.
- Mastercard Inc (NYSE:MA): Ranked #25 globally with a market cap of $452.61 Billion USD.
- American Express Company (NYSE:AXP): Ranked #105 globally with a market cap of $159.10 Billion USD.
- Capital One Financial Corporation (NYSE:COF): Ranked #177 globally with a market cap of $110.13 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #20 | Visa Inc. Class A | NYSE:V | $539.53 Billion | $310.11 |
| #25 | Mastercard Inc | NYSE:MA | $452.61 Billion | $508.50 |
| #105 | American Express Company | NYSE:AXP | $159.10 Billion | $298.20 |
| #177 | Capital One Financial Corporation | NYSE:COF | $110.13 Billion | $180.77 |
Ventana Biotech Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Ventana Biotech Inc's market cap moved from $43.03K to $ 591.62K, with a yearly change of 30.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $591.62K | +2650.00% |
| 2024 | $21.51K | -80.95% |
| 2023 | $112.95K | +5.00% |
| 2022 | $107.57K | -20.00% |
| 2021 | $134.46K | -83.33% |
| 2020 | $806.75K | +154.24% |
| 2019 | $317.32K | +742.86% |
| 2018 | $37.65K | 0.00% |
| 2017 | $37.65K | -30.00% |
| 2016 | $53.78K | +25.00% |
| 2015 | $43.03K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Ventana Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $591.62K USD |
| MoneyControl | $591.62K USD |
| MarketWatch | $591.62K USD |
| marketcap.company | $591.62K USD |
| Reuters | $591.62K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.